Key result
Newer LVADs improve outcomes as an increasingly key therapy in end-stage heart failure.
Answers are grounded in this paper and cite their sources.
Left ventricular assist devices (LVADs) have changed the landscape of treatment options for patients with end stage heart failure. Due to the limited availability of donor hearts for transplantation, LVADs have become an important option for many of these patients. Much progress has been made in the device industry since then, and newer devices continue to improve patient outcomes. In this review, we will discuss some of the key transitions in LVADs over the years, the current LVADs used in practice today, implantation techniques, the impact of the new heart allocation system on LVAD use and future prospective LVADs.
No takes yet. Share an insight, caveat, or question.
Javorski et al. (2021) conducted a review in End stage heart failure. Left ventricular assist devices (LVADs) was evaluated. Left ventricular assist devices (LVADs) provide an increasingly important treatment option for patients with end-stage heart failure, with newer devices continuing to improve patient outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: